SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
12829890
Source:
http://linkedlifedata.com/resource/pubmed/id/12829890
Search
Subject
(
59
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0023981
,
umls-concept:C0034656
,
umls-concept:C0072980
,
umls-concept:C0085149
,
umls-concept:C0205195
,
umls-concept:C1096776
,
umls-concept:C1709854
pubmed:issue
12
pubmed:dateCreated
2003-6-27
pubmed:abstractText
Recently, sirolimus (SRL) was introduced as an immunosuppressant in solid-organ transplantation. This study evaluated combinations of SRL and tacrolimus (Tac).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0132144
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Sirolimus
,
http://linkedlifedata.com/resource/pubmed/chemical/Tacrolimus
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0041-1337
pubmed:author
pubmed-author:PaczekLeszekL
,
pubmed-author:SquiffletJean-PaulJP
,
pubmed-author:VanrenterghemYvesY
,
pubmed-author:WlodarczykZbigniewZ
,
pubmed-author:van HooffJohannes PJP
pubmed:issnType
Print
pubmed:day
27
pubmed:volume
75
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1934-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12829890-Adult
,
pubmed-meshheading:12829890-Continental Population Groups
,
pubmed-meshheading:12829890-Drug Administration Schedule
,
pubmed-meshheading:12829890-Drug Therapy, Combination
,
pubmed-meshheading:12829890-Europe
,
pubmed-meshheading:12829890-Female
,
pubmed-meshheading:12829890-Follow-Up Studies
,
pubmed-meshheading:12829890-Graft Rejection
,
pubmed-meshheading:12829890-Graft Survival
,
pubmed-meshheading:12829890-Humans
,
pubmed-meshheading:12829890-Immunosuppressive Agents
,
pubmed-meshheading:12829890-Kidney Transplantation
,
pubmed-meshheading:12829890-Male
,
pubmed-meshheading:12829890-Middle Aged
,
pubmed-meshheading:12829890-Prospective Studies
,
pubmed-meshheading:12829890-Sirolimus
,
pubmed-meshheading:12829890-Tacrolimus
,
pubmed-meshheading:12829890-Time Factors
,
pubmed-meshheading:12829890-Tissue Donors
pubmed:year
2003
pubmed:articleTitle
A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipients.
pubmed:affiliation
Academisch Ziekenhuis Maastricht, Department of Internal Medicine, Maastricht, The Netherlands. jho@sint.azm.nl
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study